HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$119.63
-4.48 (-3.61%)
As of Nov 7, 1:36 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.27B
Net Income
92.50M
Gross Margin
59.0%
Profit Margin
7.3%
Rev Growth
+4.5%
D/E Ratio
1.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.27B 1.21B 2.17B 1.94B
Gross Profit 748.18M 715.90M 1.18B 1.05B
Operating Income 149.00M 128.32M 248.79M 212.97M
Net Income 92.50M 79.66M 171.22M 125.72M
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Rev Growth +4.5% +4.5% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.63B 1.63B 666.77M 805.22M
Total Equity 1.06B 1.06B 1.73B 1.53B
D/E Ratio 1.54 1.54 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 190.81M 173.45M 302.84M 250.08M
Free Cash Flow — — 163.13M 182.49M